ValoreQ4, 24Q1, 25Q2, 25Q3, 25TTMSpese di vendita, generali e amministrative1.98 B2.2 B2.07 B2.03 B8.28 BRicerca e sviluppo—————Reddito operativo1.59 B1.04 B1.41 B1.62 B5.65 BProventi non operativi, Totale-31 M64 M62 M74 M169 MOneri finanziari, al netto degli interessi capitalizzati45 M49 M74 M63 M231 MProventi non operativi, esclusi gli oneri finanziari195 M15 M-12 M11 M209 MEntrate/uscite straordinarie-271 M————Utile al lordo delle imposte1.51 B1.05 B1.4 B1.63 B5.59 BQuota di utile52 M————Imposte209 M220 M232 M380 M1.04 BInteressi di minoranza46 M47 M53 M64 M210 MAltri proventi/oneri al netto delle imposte-213 M-57 M-112 M-40 M-422 MUtile netto al lordo delle attività cessate1.26 B784 M1.11 B1.19 B4.34 BAttività cessate0————Utile netto1.26 B784 M1.11 B1.19 B4.34 BRegolazione della diluizione—————Dividendi privilegiati—————Utile netto diluito attribuibile agli azionisti ordinari1.26 B784 M1.11 B1.19 B4.34 BUtile base per azione (EPS base)9.966.288.959.6334.82Utile diluito per azione (EPS diluito)9.96.258.929.5934.66Numero medio di azioni ordinarie in circolazione127.4 M124.9 M124 M123.2 M499.5 MAzioni diluite in circolazione128.1 M125.5 M124.4 M123.7 M501.7 MEBITDA1.74 B1.19 B1.59 B1.81 B6.34 BEBIT1.59 B1.04 B1.41 B1.62 B5.65 BCosto del fatturato87.18 B94.55 B99.61 B102.47 B383.81 BAltri costi del venduto—————Ammortamento e svalutazione (liquidità)151 M157 M188 M188 M684 M
McKesson Corporation
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.